Alireza Mousavian1, Mohammad H Ebrahimzadeh2, Ali Birjandinejad3, Farzad Omidi-Kashani4, Amir Reza Kachooei5. 1. Orthopedic Research Center, Mashhad University of Medical Sciences, Ahmad-Abad Street, Mashhad 91766-99199, Iran. Electronic address: Mousaviana@mums.ac.ir. 2. Orthopedic Research Center, Mashhad University of Medical Sciences, Ahmad-Abad Street, Mashhad 91766-99199, Iran. Electronic address: Ebrahimzadehmh@mums.ac.ir. 3. Orthopedic Research Center, Mashhad University of Medical Sciences, Ahmad-Abad Street, Mashhad 91766-99199, Iran. Electronic address: Birjandinejada@mums.ac.ir. 4. Orthopedic Research Center, Mashhad University of Medical Sciences, Ahmad-Abad Street, Mashhad 91766-99199, Iran. Electronic address: Omidif@mums.ac.ir. 5. Orthopedic Research Center, Mashhad University of Medical Sciences, Ahmad-Abad Street, Mashhad 91766-99199, Iran; Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA. Electronic address: kachoeear@mums.ac.ir.
Abstract
PURPOSE: In this study, we aimed to translate and test the validity and reliablity of the Persian version of the Manchester-Oxford Foot Questionnaire in foot and ankle patients. METHODS: We translated the Manchester-Oxford Foot Questionnaire to Persian language according to the accepted guidelines, then assessed the psychometric properties including the validity and reliability on 308 patients with long-standing foot and ankle problems. To test the reliability, we calculated the intra-class correlation coefficient (ICC) for test-retest reliability and measured Cronbach's alpha to test the internal consistency. To test the construct validity of the Manchester-Oxford Foot Questionnaire we also administered the Short-Form 36 to patients. RESULTS: Construct validity was supported by significant correlation with SF36 subscales except for pain subscale of the persian MOXFQ with mental health of the SF36 (r=0.207). Intraclass correlation coefficient was 0.79 for the total MOXFQ and ranged from 0.83 to 0.89 for the three subscales. Cronbach's alpha for pain, walking/standing, and social interaction was 0.86, 0.88, and 0.89, respectively, and was 0.79 for the total MOXFQ showing good internal consistency in each domain. CONCLUSION: The Persian Manchester-Oxford Foot Questionnaire health scoring system is a valid and reliable patient-reported instrument for foot and ankle problems.
PURPOSE: In this study, we aimed to translate and test the validity and reliablity of the Persian version of the Manchester-Oxford Foot Questionnaire in foot and ankle patients. METHODS: We translated the Manchester-Oxford Foot Questionnaire to Persian language according to the accepted guidelines, then assessed the psychometric properties including the validity and reliability on 308 patients with long-standing foot and ankle problems. To test the reliability, we calculated the intra-class correlation coefficient (ICC) for test-retest reliability and measured Cronbach's alpha to test the internal consistency. To test the construct validity of the Manchester-Oxford Foot Questionnaire we also administered the Short-Form 36 to patients. RESULTS: Construct validity was supported by significant correlation with SF36 subscales except for pain subscale of the persian MOXFQ with mental health of the SF36 (r=0.207). Intraclass correlation coefficient was 0.79 for the total MOXFQ and ranged from 0.83 to 0.89 for the three subscales. Cronbach's alpha for pain, walking/standing, and social interaction was 0.86, 0.88, and 0.89, respectively, and was 0.79 for the total MOXFQ showing good internal consistency in each domain. CONCLUSION: The Persian Manchester-Oxford Foot Questionnaire health scoring system is a valid and reliable patient-reported instrument for foot and ankle problems.
Authors: Alireza Mousavian; Ali Mohammadi; Seyed-Hadi Seyed-Hosseinian; Omid Shahpari; Nafiseh Elahpour; Arezoo Orooji; Mohammad H Ebrahimzadeh; Ali Moradi Journal: Arch Bone Jt Surg Date: 2019-05
Authors: Alireza Mousavian; Amir Reza Kachooie; Ali Birjandinejad; Masood Khoshsaligheh; Mohammad Hosein Ebrahimzadeh Journal: Int J Prev Med Date: 2018-02-28